PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL)
CUSIP: 74019P207
Q2 2025 13F Holders as of 30 Jun 2025
- Type / Class
- Equity / Common Stock, par value $0.000005 per share
- Shares outstanding
- 24,241,780
- Total 13F shares
- 4,437,938
- Share change
- +651,590
- Total reported value
- $18,638,020
- Price per share
- $4.20
- Number of holders
- 51
- Value change
- +$2,152,791
- Number of buys
- 24
- Number of sells
- 15
Quarterly Holders Quick Answers
What is CUSIP 74019P207?
CUSIP 74019P207 identifies DTIL - PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 74019P207:
Top shareholders of DTIL - PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Readout Capital, LP |
13D/G
|
Matthew Smith |
9.4%
|
1,119,311
|
$4,980,934 | +$829,645 | 30 Jun 2025 | |
| NOVARTIS PHARMA AG |
3/4/5
13D/G
|
10%+ Owner |
3.7%
from 13D/G
|
12,407,440
|
$4,590,753 | — | 15 Jun 2022 | |
| Lynx1 Capital Management LP |
13F
|
Company |
3.2%
|
766,051
|
$3,654,063 | — | 31 Mar 2025 | |
| Aquilo Capital Management, LLC |
13F
|
Company |
3%
|
726,149
|
$3,463,731 | — | 31 Mar 2025 | |
| TANG CAPITAL MANAGEMENT LLC |
13F
|
Company |
2.8%
|
673,332
|
$3,211,794 | — | 31 Mar 2025 | |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13D/G
|
— |
3.7%
|
406,250
|
$2,165,312 | $0 | 31 Mar 2025 | |
| Weinstein Benjamin |
13D/G
|
— |
5.2%
|
395,489
|
$2,107,956 | $0 | 18 Mar 2025 | |
| Derek Jantz |
3/4/5
|
Chief Scientific Officer, Director |
—
mixed-class rows
|
4,079,565
mixed-class rows
|
$1,509,439 | — | 07 Jun 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.2%
|
281,083
|
$1,340,765 | — | 31 Mar 2025 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
1%
|
248,620
|
$1,184,000 | — | 31 Mar 2025 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.83%
|
200,000
|
$954,000 | — | 31 Mar 2025 | |
| BALYASNY ASSET MANAGEMENT L.P. |
13F
|
Company |
0.78%
|
189,665
|
$904,705 | — | 31 Mar 2025 | |
| Matthew R. Kane |
3/4/5
|
President and CEO, Director |
—
mixed-class rows
|
2,026,513
mixed-class rows
|
$749,324 | — | 07 Jun 2021 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.34%
|
82,977
|
$395,800 | — | 31 Mar 2025 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.3%
|
73,687
|
$351,527 | — | 31 Mar 2025 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.27%
|
65,586
|
$312,845 | — | 31 Mar 2025 | |
| Tejara Capital Ltd |
13F
|
Company |
0.25%
|
60,427
|
$288,237 | — | 31 Mar 2025 | |
| UBS Group AG |
13F
|
Company |
0.24%
|
57,027
|
$272,019 | — | 31 Mar 2025 | |
| BlackRock, Inc. |
13F
|
Company |
0.23%
|
54,819
|
$261,487 | — | 31 Mar 2025 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.22%
|
53,631
|
$255,820 | — | 31 Mar 2025 | |
| Kevin Buehler |
3/4/5
|
Director |
—
mixed-class rows
|
49,137
mixed-class rows
|
$234,961 | +$21,116 | 25 Jun 2025 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.18%
|
43,027
|
$205,239 | — | 31 Mar 2025 | |
| Moloney Securities Asset Management, LLC |
13F
|
Company |
0.18%
|
42,866
|
$204,471 | — | 31 Mar 2025 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.17%
|
40,000
|
$191,000 | — | 31 Mar 2025 | |
| Shari Lisa Pire |
3/4/5
|
Director |
—
mixed-class rows
|
35,028
mixed-class rows
|
$189,875 | — | 27 May 2025 | |
| COMMONWEALTH EQUITY SERVICES, LLC |
13F
|
Company |
0.15%
|
37,155
|
$177,000 | — | 31 Mar 2025 | |
| Samuel C. Wadsworth |
3/4/5
|
Director |
—
mixed-class rows
|
14,028
mixed-class rows
|
$161,277 | — | 04 Jun 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.09%
|
22,042
|
$105,140 | — | 31 Mar 2025 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.06%
|
13,565
|
$64,705 | — | 31 Mar 2025 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
12,271
|
$58,533 | — | 31 Mar 2025 | |
| Bleichroeder LP |
13F
|
Company |
0.05%
|
12,077
|
$57,607 | — | 31 Mar 2025 | |
| Alan List |
3/4/5
|
Chief Medical Officer |
—
mixed-class rows
|
5,469
mixed-class rows
|
$56,440 | — | 01 May 2024 | |
| Miller Financial Services LLC |
13F
|
Company |
0.04%
|
10,000
|
$47,700 | — | 31 Mar 2025 | |
| David S. Thomson |
3/4/5
|
Chief Operating Officer |
—
mixed-class rows
|
130,768
mixed-class rows
|
$41,260 | — | 23 Jun 2021 | |
| Allworth Financial LP |
13F
|
Company |
0.02%
|
4,769
|
$26,230 | — | 31 Mar 2025 | |
| NATIONAL BANK OF CANADA /FI/ |
13F
|
Company |
0.02%
|
5,000
|
$23,600 | — | 31 Mar 2025 | |
| Vivo Capital, LLC |
13F
|
Company |
0.02%
|
4,675
|
$22,301 | — | 31 Mar 2025 | |
| Shane Barton |
3/4/5
|
VP & Corporate Controller |
—
mixed-class rows
|
33,562
mixed-class rows
|
$12,418 | — | 07 Jun 2023 | |
| Fayaz Khazi |
3/4/5
|
CEO of Elo Life Systems |
—
mixed-class rows
|
65,239
mixed-class rows
|
$8,880 | — | 07 Jun 2021 | |
| Newbridge Financial Services Group, Inc. |
13F
|
Company |
0.01%
|
1,600
|
$7,632 | — | 31 Mar 2025 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.01%
|
1,500
|
$7,155 | — | 31 Mar 2025 | |
| CWM, LLC |
13F
|
Company |
0%
|
1,005
|
$5,000 | — | 31 Mar 2025 | |
| SBI Securities Co., Ltd. |
13F
|
Company |
0%
|
470
|
$2,242 | — | 31 Mar 2025 | |
| BARCLAYS PLC |
13F
|
Company |
0%
|
384
|
$1,832 | — | 31 Mar 2025 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0%
|
275
|
$1,311 | — | 31 Mar 2025 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
132
|
$630 | — | 31 Mar 2025 | |
| FMR LLC |
13F
|
Company |
0%
|
100
|
$477 | — | 31 Mar 2025 | |
| SouthState Bank Corp |
13F
|
Company |
0%
|
95
|
$453 | — | 31 Mar 2025 | |
| Zurcher Kantonalbank (Zurich Cantonalbank) |
13F
|
Company |
0%
|
69
|
$329 | — | 31 Mar 2025 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0%
|
55
|
$262 | — | 31 Mar 2025 |
Institutional Holders of PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) as of Q2 2025
As of 30 Jun 2025,
PRECISION BIOSCIENCES INC - Common Stock, par value $0.000005 per share (DTIL) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,437,938 shares.
The largest 10 holders included
Bleichroeder LP, Lynx1 Capital Management LP, TANG CAPITAL MANAGEMENT LLC, VANGUARD GROUP INC, ACADIAN ASSET MANAGEMENT LLC, BOOTHBAY FUND MANAGEMENT, LLC, Corient Private Wealth LLC, RENAISSANCE TECHNOLOGIES LLC, GEODE CAPITAL MANAGEMENT, LLC, and BRIDGEWAY CAPITAL MANAGEMENT, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q2 2025 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2025 vs Q1 2025 Across Filers
Q1 2025 holders
47
Q2 2025 holders
51
Holder diff
4
| Investor | Q1 2025 Shares | Q2 2025 Shares | Share Diff | Share Chg % | Q1 2025 Value $ | Q2 2025 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.